rhodamine 123 has been researched along with Granuloma Gangraenescens in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukumoto, M; Kita, K; Miwa, H; Nishii, K; Ohno, T; Oka, K; Shirakawa, S; Yamaguchi, M | 1 |
1 other study(ies) available for rhodamine 123 and Granuloma Gangraenescens
| Article | Year |
|---|---|
Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.
Topics: Adult; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Combined Modality Therapy; Drug Resistance, Multiple; Female; Fluorescent Antibody Technique, Direct; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Granuloma, Lethal Midline; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Male; Nose Diseases; Nose Neoplasms; Phenotype; Polymerase Chain Reaction; Retrospective Studies; Rhodamine 123; Rhodamines; RNA, Messenger; T-Lymphocytes; Transcription, Genetic; Treatment Outcome | 1995 |